Вся информация в резюме.

Публикации за последние 10 лет
[1] Хмелькова Д. Н., Волкова М. И., Гриднева Я. В., Благодатских К. А., Миро-
нова И. В., Семенова А. Б., Вещевайлов А. А., Бабкина А. В., Бондарев С.
А., and Галкин В. Н. Мутационный профиль мышечно-инвазивной уроте-
лиальной карциномы и его взаимосвязь с течением опухолевого процесса.
15(3):17–28, Oct. 2025. Section: ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ.
[2] E. V. Smirnova, K. A. Blagodatskikh, E. V. Barsova, D. A. Varlamov, V. M.
Kramarov, and K. B. Ignatov. Comparison of Commercially Available
Thermostable DNA Polymerases with Reverse Transcriptase Activity in Coupled
Reverse Transcription Polymerase Chain Reaction Assays. Methods and
Protocols, 8(1):11, Feb. 2025. Number: 1 Publisher: Multidisciplinary Digital
Publishing Institute.
[3] E. V. Smirnova, E. V. Barsova, D. A. Varlamov, K. A. Blagodatskikh, and K. B.
Ignatov. Strand Displacement Chain Reaction (SDCR): New Hybrid Amplification
Technique for Fast and Sensitive Detection of Genetic Materials. 2025.
[4] D. K. Lukyanov, V. V. Kriukova, K. Ladell, I. A. Shagina, D. B. Staroverov, B. E.
Minasian, A. S. Fedosova, P. Shelyakin, O. N. Suchalko, A. Y. Komkov, K. A.
Blagodatskikh, K. L. Miners, O. V. Britanova, A. Franke, D. A. Price, and D. M. Chudakov. Repertoire-based mapping and time-tracking of T helper cell subsets
in scRNA-Seq. Frontiers in Immunology, 16:1536302, Apr. 2025. Publisher:
Frontiers.
[5] M. Guseva, N. Shirokova, O. Kapitonova, V. Gnetetskaya, K. Blagodatskikh,
J. Tarasova, V. Kaimonov, A. Korbut, and E. Musatova. Application of Whole-
Exome Sequencing (WES) for Prenatal Determination of Causes of Fetal
Abnormalities. Genes, 16(5):547, Apr. 2025.
[6] Yana V. Gridneva, Darya N. Khmelkova, Maria I. Volkova, K. A. Blagodatskikh,
Anna A. Zheludkevich, Anna B. Semenova, Alexander A. Veshchevailov,
Alexandra V. Babkina, Sergey A. Bondarev, and Vsevolod N. Galkin. Experience
of Next-Generation Sequencing in urothelial carcinoma specimens with panel for
523 genes. Journal of Modern Oncology, 26(4):489–494, 2024.
[7] S. N. Bardakov, R. V. Deev, V. A. Tsargush, V. S. Kaimonov, E. V. Musatova, K. A.
Blagodatskikh, A. A. Tveleneva, Y. V. Sofronova, V. M. Suslov, P. G. Carlier, S. A.
Kurbatov, I. A. Yakovlev, Z. R. Umakhanova, and A. A. Isaev. Asymptomatic and
oligosymptomatic states of dysferlinopathy. Journal of Neuromuscular Diseases,
11(6):1283–1294, Nov. 2024.
[8] A. V. Kudriavtsev, A. V. Vakhrusheva, N. A. Kryuchkov, M. E. Frolova, K. A.
Blagodatskikh, T. V. Ivanishin, M. Djonovic, E. A. Romanovskaya-Romanko,
A. N. Kovalenko, D. A. Lioznov, T. G. Zubkova, S. V. Teplykh, R. A. Oseshnyuk,
M. A. Stukova, A. A. Isaev, and I. V. Krasilnikov. Safety and Immunogenicity
of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine:
Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-
Controlled Phase I/II Clinical Trial. Vaccines, 11(2):326, Feb. 2023.
[9] A. Koval, A. Khromova, K. Blagodatskikh, Y. Zhitnyuk, Y. Shtykova, A. Alferov,
N. Kushlinskii, and D. Shcherbo. Application of PCR-based approaches for
evaluation of cell-free DNA fragmentation in colorectal cancer. Frontiers in
Molecular Biosciences, 10, Mar. 2023.
[10] A. V. Vakhrusheva, A. V. Kudriavtsev, N. A. Kryuchkov, R. V. Deev, M. E. Frolova,
K. A. Blagodatskikh, M. Djonovic, A. A. Nedorubov, E. Odintsova, A. V. Ivanov,
E. A. Romanovskaya-Romanko, M. A. Stukova, A. A. Isaev, and I. V. Krasilnikov.
SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and
Protective Efficacy: Preclinical Study. Vaccines, 10(8):1290, Aug. 2022.
[11] M. Burdukiewicz, A.-N. Spiess, D. Rafacz, K. Blagodatskikh, and S. Rödiger.
PCRedux: A Quantitative PCR Machine Learning Toolkit. Journal of Open
Source Software, 7(76):4407, Aug. 2022.
[12] A. Barchuk, D. Skougarevskiy, A. Kouprianov, D. Shirokov, O. Dudkina,
R. Tursun-zade, M. Sergeeva, V. Tychkova, A. Komissarov, A. Zheltukhina,
D. Lioznov, A. Isaev, E. Pomerantseva, S. Zhikrivetskaya, Y. Sofronova,
K. Blagodatskikh, K. Titaev, L. Barabanova, and D. Danilenko. COVID-19
pandemic in Saint Petersburg, Russia: Combining population-based serological
study and surveillance data. PLOS ONE, 17(6):e0266945, 2022. Publisher:
Public Library of Science.

[13] A. P. Koval, K. A. Blagodatskikh, N. E. Kushlinskii, and D. S. Shcherbo. The
Detection of Cancer Epigenetic Traces in Cell-Free DNA. Frontiers in Oncology,
11, 2021. Publisher: Frontiers.
[14] A. Barchuk, D. Skougarevskiy, A. Kouprianov, D. Shirokov, O. Dudkina,
R. Tursun-zade, M. Sergeeva, V. Tychkova, A. Komissarov, A. Zheltukhina,
D. Lioznov, A. Isaev, E. Pomerantseva, S. Zhikrivetskaya, Y. Sofronova,
K. Blagodatskikh, K. Titaev, L. Barabanova, and D. Danilenko. COVID-19
pandemic in Saint Petersburg, Russia: combining surveillance and populationbased
serological study data in May, 2020–April, 2021. preprint, Epidemiology,
Aug. 2021.
[15] D. A. Varlamov, K. A. Blagodatskikh, E. V. Smirnova, V. M. Kramarov, and K. B.
Ignatov. Combinations of PCR and Isothermal Amplification Techniques Are
Suitable for Fast and Sensitive Detection of SARS-CoV-2 Viral RNA. Frontiers
in Bioengineering and Biotechnology, 8:1294, 2020.
[16] K. Blagodatskikh, D. Romaniuk, and D. Malko. AScall – Automatic Allele-Specific
qPCR Analysis. Frontiers in Bioengineering and Biotechnology, 8:353, 2020.
[17] K. B. Ignatov, K. A. Blagodatskikh, D. S. Shcherbo, T. V. Kramarova, Y. A.
Monakhova, and V. M. Kramarov. Fragmentation Through Polymerization (FTP):
A new method to fragment DNA for next-generation sequencing. PLOS ONE,
14(4):e0210374, Apr. 2019.
[18] M. Burdukiewicz, A.-N. Spiess, K. A. Blagodatskikh, W. Lehmann, P. Schierack,
and S. Rödiger. Algorithms for automated detection of hook effect-bearing
amplification curves. Biomolecular Detection and Quantification, Oct. 2018.
[19] S. Rödiger, M. Burdukiewicz, A.-N. Spiess, and K. Blagodatskikh. Enabling
reproducible real-time quantitative PCR research: the RDML package. Oxford
Bioinformatics, 2017.
[20] K. A. Blagodatskikh, V. M. Kramarov, E. V. Barsova, A. V. Garkovenko, D. S.
Shcherbo, A. A. Shelenkov, V. V. Ustinova, M. R. Tokarenko, S. C. Baker, T. V.
Kramarova, and K. B. Ignatov. Improved DOP-PCR (iDOP-PCR): A robust and
simple WGA method for efficient amplification of low copy number genomic DNA.
PLOS ONE, 12(9):e0184507, Sept. 2017.
[21] N. Zlobin, K. Evlakov, Y. Alekseev, K. Blagodatskikh, A. Babakov, and
V. Taranov. High DNA melting activity of extremophyte Eutrema salsugineum
cold shock domain proteins EsCSDP1 and EsCSDP3. Biochemistry and
Biophysics Reports, 5:502–508, Mar. 2016.
[22] V. Ustinova, T. Smirnova, K. Blagodatskikh, D. Varlamov, D. Sochivko,
E. Larionova, S. Andreevskaya, I. Andrievskaya, and L. Chernousova. First
Draft Genome Sequence of a Mycobacterium gordonae Clinical Isolate. Genome
Announcements, 4(3), June 2016.
[23] Владимирский М. А., Смирнова Н.С., Шипина Л.К., Ильина Е.А., Благодат-
ских К.А., and Алексеев Я.И. Новый ускоренный культуральный метод опре-
деления чувствитель противотуберкулезных препаратов на основе применения микобактерио-
фагов. ТУБЕРКУЛЕЗ И БОЛЕЗНИ ЛЕГКИХ, (5):59–61, 2015.
[24] Stefan Rödiger, Michał Burdukiewicz, Konstantin Blagodatskikh, Michael Jahn,
and Peter Schierack. R as an Environment for the Reproducible Analysis of DNA
Amplification Experiments. The R Journal, 7(1), 2015.ности микобактерий туберкулеза к широкому спектру